Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Regulatory press release

Nexam Chemical intends to undertake a directed new share issue amounting to SEK 30 million

Nexam Chemical Holding
Read the release

Nexam Chemical Holding AB ("Nexam Chemical" or the "Company") today announces its intentions to carry out a directed new share issue of SEK 30 million to primarily Swedish and international institutional investors (the "Directed New Share Issue").

The transaction in brief

The Directed New Share Issue is intended to be carried out with deviation from the shareholders' preferential rights and with the support of the authorization granted by the annual general meeting held on May 13, 2020. Nexam Chemical has engaged Erik Penser Bank ("Erik Penser Bank") to investigate the conditions  for a new issue of shares through a so-called accelerated bookbuilding procedure, which will commence immediately after the disclosure of this press release. The subscription price and allocation of the new shares will be determined prior to commencement of trading on Nasdaq First North Premier Growth Market on February 2, 2020. The Company will announce the outcome of the Directed New Share Issue in a press release when the bookbuilding procedure is closed.

The bookbuilding procedure, determination of the subscription price and allocation may, at the discretion of the Company or Erik Penser Bank, close earlier or later and may be cancelled at any time and consequently, the Company may refrain from completing the Directed New Share Issue.

Background and use of proceeds

The main rationale for carrying out the Directed New Share Issue is to strengthen the Company's financial position and to enable a continued high growth rate, which includes investments in production capacity, product development, strengthening of working capital and the Company's sales organization.

The reasons for the deviation from the shareholders' preferential rights are mainly to diversify the shareholder base in the Company among Swedish and international institutional investors and at the same time take advantage of the opportunity to raise capital in a time- and cost-efficient manner.

Advisors

Erik Penser Bank is Sole Manager and Bookrunner and Setterwalls Advokatbyrå AB is legal advisor to the Company in connection with the Directed New Share Issue.

For more information, please contact:

Johan Arvidsson, CEO, +46-708 97 44 39, johan.arvidsson@nexamchemical.com

This information is information that Nexam Chemical Holding AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 17:31 CET on February 1, 2021.

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.